Therapeutic implications of GIPC1 silencing in cancer.
Chittenden TW, Pak J, Rubio R, Cheng H, Holton K, Prendergast N, Glinskii V, Cai Y, Culhane A, Bentink S, Schwede M, Mar JC, Howe EA, Aryee M, Sultana R, Lanahan AA, Taylor JM, Holmes C, Hahn WC, Zhao JJ, Iglehart JD, Quackenbush J.
Chittenden TW, et al.
PLoS One. 2010 Dec 30;5(12):e15581. doi: 10.1371/journal.pone.0015581.
PLoS One. 2010.
PMID: 21209904
Free PMC article.